Related Experiment Video

Updated: Aug 2, 2026

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
09:38

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Published on: March 28, 2018

On the track of antitumour ribonucleases

Antoni Benito1, Marc Ribó, Maria Vilanova

  • 1Laboratori d'Enginyeria de Proteïnes, Facultat de Ciències, Universitat de Girona, Girona, Spain.

Molecular Biosystems
|August 2, 2006
PubMed

Insights

Ribonucleases (RNases) show promise as non-mutagenic anticancer drugs. Their tumor-selective cytotoxicity depends on cellular uptake, RNA cleavage, and apoptosis induction, with efficiency varying by enzyme.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Ribonucleases (RNases) are explored as potential non-mutagenic anticancer agents.
  • Certain RNases, including onconase and bovine-seminal ribonuclease, exhibit selective cytotoxicity against tumor cells.

Purpose of the Study:

  • To elucidate the mechanism of tumor-selective cytotoxicity of specific RNases.
  • To understand the key steps involved in RNase-mediated cancer cell death.

Main Methods:

  • The study reviews the accepted model for RNase cytotoxicity.
  • It examines the steps of cell membrane interaction, endocytosis, cytosolic translocation, and RNA cleavage.

Main Results:

  • Cytotoxicity requires RNase interaction with the cell membrane and endocytosis.
  • Successful translocation to the cytosol and preservation of ribonucleolytic activity are crucial.
  • Cleavage of cellular RNA induces apoptosis, though not solely through protein synthesis inhibition.

Conclusions:

  • The potency of an RNase as an anticancer agent is determined by its efficiency in each step of the cytotoxicity mechanism.
  • Understanding these steps can guide the development of more effective RNase-based cancer therapies.

More Related Videos

Studying Ribonucleotide Incorporation: Strand-specific Detection of Ribonucleotides in the Yeast Genome and Measuring Ribonucleotide-induced Mutagenesis09:04

Studying Ribonucleotide Incorporation: Strand-specific Detection of Ribonucleotides in the Yeast Genome and Measuring Ribonucleotide-induced Mutagenesis

Published on: July 26, 2018

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases10:24

NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases

Published on: June 30, 2019

Related Concept Videos

Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribosome Profiling02:24

Ribosome Profiling

Ribosome profiling or ribo-sequencing is a deep sequencing technique that produces a snapshot of active translation in a cell. It selectively sequences the mRNAs protected by ribosomes to get an insight into a cell’s translation landscape at any given point in time.
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique helps...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Ribozymes02:47

Ribozymes

The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...